Ultragenyx (RARE) CFO sells 4,698 shares, retains 100,991 stake
Rhea-AI Filing Summary
Ultragenyx Pharmaceutical Inc. Chief Financial Officer Howard Horn reported an open-market sale of 4,698 shares of common stock at a price of $33.13 per share. After this transaction, he directly owns 100,991 shares. His reported holdings include shares underlying previously granted RSUs that vest over time.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 4,698 shares
Net Sell
1 txn
Insider
Horn Howard
Role
Chief Financial Officer
Sold
4,698 shs ($156K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 4,698 | $33.13 | $156K |
Holdings After Transaction:
Common Stock — 100,991 shares (Direct)
Footnotes (1)
- [object Object]
Key Figures
Shares sold: 4,698 shares
Sale price: $33.13 per share
Shares owned after: 100,991 shares
3 metrics
Shares sold
4,698 shares
Open-market sale of common stock
Sale price
$33.13 per share
Price for the 4,698 shares sold
Shares owned after
100,991 shares
Direct ownership following the transaction
Key Terms
Common Stock, open-market sale, RSUs
3 terms
Common Stock financial
"security_title: "Common Stock" in the transaction record"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
open-market sale financial
"transaction_action: "open-market sale" describing the trade"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
RSUs financial
"shares of common stock underlying RSUs granted to the Reporting Person"
RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Ultragenyx (RARE) disclose for CFO Howard Horn?
Ultragenyx reported that CFO Howard Horn sold 4,698 shares of common stock. The shares were sold in an open-market transaction at $33.13 per share, and he continues to hold 100,991 shares directly after the sale.
Was the Ultragenyx (RARE) CFO trade a buy or a sell?
The Ultragenyx CFO transaction was a sale of shares. The Form 4 uses transaction code "S" and describes the action as an open-market sale, indicating that 4,698 common shares were sold rather than acquired.
Do Ultragenyx (RARE) CFO holdings include RSUs after this Form 4?
Yes, the CFO’s reported holdings include shares underlying RSUs. A footnote explains that the total common stock count incorporates previously reported RSU awards that are still subject to vesting conditions, which may affect when those shares fully vest.